LL-37
Phase ICathelicidin · hCAP18/LL-37
LL-37 is the only known human cathelicidin antimicrobial peptide, derived from the C-terminus of hCAP18 protein. It exhibits broad-spectrum antimicrobial activity against bacteria, fungi, and viruses by disrupting microbial membranes. Beyond direct killing, LL-37 modulates inflammation, promotes wound healing, and may have anticancer properties. Research focuses on chronic wound care, infection, and skin disorders like rosacea.
AntimicrobialImmune SupportHealing & Recovery